We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-0.88%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$227M
AUM Growth
-$15.9M
Cap. Flow
-$6.57M
Cap. Flow %
-2.89%
Top 10 Hldgs %
7.9%
Holding
407
New
8
Increased
60
Reduced
329
Closed
10

Top Buys

Rank Stock Value
1
XFLT
XAI Floating Rate & Alternative Income Trust
XFLT
+$689K
2
VTA
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
+$551K
3
FRA icon
BlackRock Floating Rate Income Strategies Fund
FRA
+$468K
4
ENIC icon
Enel Chile
ENIC
+$430K
5
EFT
Eaton Vance Floating-Rate Income Trust
EFT
+$429K

Top Sells

Rank Stock Value
1
GRA
W.R. Grace & Co.
GRA
+$1.73M
2
BGX
Blackstone Long-Short Credit Income Fund
BGX
+$731K
3
BGB
Blackstone Strategic Credit 2027 Term Fund
BGB
+$693K
4
NOA
North American Construction
NOA
+$554K
5
MCI
Barings Corporate Investors
MCI
+$524K

Sector Composition

Rank Sector Weight
1 Healthcare 25.28%
2 Real Estate 19.7%
3 Energy 13.28%
4 Utilities 12%
5 Materials 10.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENTA icon
126
Enanta Pharmaceuticals
ENTA
$370M
$545K 0.24%
9,599
-884
-8% -$43.7K
BSL
127
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$168M
$540K 0.24%
32,875
-511
-2% -$8.33K
ADCT icon
128
ADC Therapeutics
ADCT
$145M
$536K 0.24%
19,728
-1,812
-8% -$46.4K
IRWD icon
129
Ironwood Pharmaceuticals
IRWD
$644M
$531K 0.23%
40,695
-3,726
-8% -$48.2K
NSL
130
DELISTED
NUVEEN SENIOR INCM FD
NSL
$531K 0.23%
90,768
-238
-0.3% -$1.38K
REGN icon
131
Regeneron Pharmaceuticals
REGN
$69.9B
$521K 0.23%
861
-83
-9% -$51.5K
ALNY icon
132
Alnylam Pharmaceuticals
ALNY
$37.2B
$518K 0.23%
2,745
-251
-8% -$47.1K
DSU icon
133
BlackRock Debt Strategies Fund
DSU
$591M
$518K 0.23%
44,911
-1,802
-4% -$20.5K
LGND icon
134
Ligand Pharmaceuticals
LGND
$5.96B
$517K 0.23%
5,954
-549
-8% -$42.5K
HRZN icon
135
Horizon Technology Finance
HRZN
$294M
$508K 0.22%
31,220
-1,580
-5% -$26.9K
JFR icon
136
Nuveen Floating Rate Income Fund
JFR
$1.24B
$508K 0.22%
50,430
-1,391
-3% -$13.8K
JRO
137
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$508K 0.22%
50,876
-1,822
-3% -$17.8K
GLAD icon
138
Gladstone Capital
GLAD
$430M
$501K 0.22%
22,180
-2,321
-9% -$53.4K
SGEN
139
DELISTED
Seagen Inc. Common Stock
SGEN
$497K 0.22%
2,925
-270
-8% -$42K
SRPT icon
140
Sarepta Therapeutics
SRPT
$1.68B
$491K 0.22%
5,311
-487
-8% -$37.5K
ONC
141
BeOne Medicines Ltd
ONC
$33.8B
$482K 0.21%
1,328
-120
-8% -$39.2K
SAR icon
142
Saratoga Investment
SAR
$316M
$477K 0.21%
16,583
-4,060
-20% -$112K
PHD
143
DELISTED
Pioneer Floating Rate Fund
PHD
$476K 0.21%
41,443
-402
-1% -$4.61K
EFR
144
Eaton Vance Senior Floating-Rate Fund
EFR
$314M
$472K 0.21%
32,323
-425
-1% -$6.06K
BGT icon
145
BlackRock Floating Rate Income Trust
BGT
$324M
$471K 0.21%
35,477
-941
-3% -$12.3K
DCF
146
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$471K 0.21%
49,720
+2,049
+4% +$19.6K
UTHR icon
147
United Therapeutics
UTHR
$26.3B
$470K 0.21%
2,548
-231
-8% -$45.5K
FRA icon
148
BlackRock Floating Rate Income Strategies Fund
FRA
$383M
$469K 0.21%
+35,109
New +$468K
GILD icon
149
Gilead Sciences
GILD
$162B
$469K 0.21%
6,710
-616
-8% -$43.3K
NKTR icon
150
Nektar Therapeutics
NKTR
$2.41B
$465K 0.2%
1,724
-159
-8% -$38.2K
4 5
6
7 8

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, Virtus ETF Advisers held 407 positions worth $227M, down 6.5% from $243M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.4%. Virtus ETF Advisers opened 8 new positions and exited 10, leaving the 407-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 27% a quarter earlier, followed by Real Estate and Energy.

  • Virtus ETF Advisers's largest Q3 2021 buy was XAI Floating Rate & Alternative Income Trust: 15,447 shares worth $663K.
  • Virtus ETF Advisers added most to Enel Chile in Q3 2021, an estimated $430K increase.
  • Virtus ETF Advisers's biggest Q3 2021 reduction was North American Construction, cutting an estimated $554K.
  • Virtus ETF Advisers fully exited W.R. Grace & Co. in Q3 2021, selling an estimated $1.73M.
  • Virtus ETF Advisers's ten largest holdings make up 7.9% of its $227M portfolio in Q3 2021.
  • Virtus ETF Advisers opened 8 new positions and closed 10 in Q3 2021.
  • Virtus ETF Advisers's portfolio value fell 6.5% quarter-over-quarter to $227M.

Based on Virtus ETF Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.